J Yeungnam Med Sci.  2022 Oct;39(4):278-284. 10.12701/jyms.2022.00528.

Pediatric headache: a narrative review

• Kim S

• KMID: 2534654
• DOI: http://doi.org/10.12701/jyms.2022.00528

Abstract

Headache is one of the most common neurological disorders in children and adults and can cause significant distress and disability in children and their families. The spectrum of pediatric headaches is broad, and the underlying etiology is variable. The symptoms and phenotypes of headaches in children may differ slightly from those in adults. It is important to have a good understanding of headaches in children and to distinguish between primary and secondary headaches through appropriate history assessment and neurological examination. Accurate diagnosis and appropriate drug selection are helpful for effective treatment. This article reviews headaches in children and adolescents, focusing on approaches for diagnosis and management.

Keyword

Headache; Migraine disorders; Pediatrics; Child; Adolescent

Reference

References

1. Langdon R, DiSabella MT. Pediatric headache: an overview. Curr Probl Pediatr Adolesc Health Care. 2017; 47:44–65.

2. Blume HK. Childhood headache: a brief review. Pediatr Ann. 2017; 46:e155–65.

3. Lee KH. Recent updates on treatment for pediatric migraine. J Korean Med Assoc. 2017; 60:118–25.

4. Merison K, Victorio MC. Approach to the diagnosis of pediatric headache. Semin Pediatr Neurol. 2021; 40:100920.

5. Gelfand AA. Pediatric and adolescent headache. Continuum (Minneap Minn). 2018; 24(4, Headache):1108–36.

6. GBD 2016 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017; 390:1211–59.

7. Lateef TM, Merikangas KR, He J, Kalaydjian A, Khoromi S, Knight E, et al. Headache in a national sample of American children: prevalence and comorbidity. J Child Neurol. 2009; 24:536–43.

8. Abu-Arafeh I, Razak S, Sivaraman B, Graham C. Prevalence of headache and migraine in children and adolescents: a systematic review of population-based studies. Dev Med Child Neurol. 2010; 52:1088–97.

9. Rho YI, Chung HJ, Lee KH, Eun BL, Eun SH, Nam SO, et al. Prevalence and clinical characteristics of primary headaches among school children in South Korea: a nationwide survey. Headache. 2012; 52:592–9.

10. Ahn JY, Rho YI. Headache-related disability and predictor of disability in children and adolescent. J Korean Child Neurol Soc. 2015; 23:104–10.

11. Rho YI. Prevalence of headache and headache-related disability in children and adolescents. J Korean Med Assoc. 2017; 60:112–7.

12. Özge A, Faedda N, Abu-Arafeh I, Gelfand AA, Goadsby PJ, Cuvellier JC, et al. Experts’ opinion about the primary headache diagnostic criteria of the ICHD-3rd edition beta in children and adolescents. J Headache Pain. 2017; 18:109.

13. Guidetti V, Faedda N. From 0° to 18°: how headache changes over time. Neurol Sci. 2017; 38(Suppl 1):103–6.

14. Whitehouse WP, Agrawal S. Management of children and young people with headache. Arch Dis Child Educ Pract Ed. 2017; 102:58–65.

15. Dao JM, Qubty W. Headache diagnosis in children and adolescents. Curr Pain Headache Rep. 2018; 22:17.

16. Suh ES. Recent advances in pediatric headaches. J Korean Med Assoc. 2017; 60:109–11.

17. Moak JP, Leong D, Fabian R, Freedenberg V, Jarosz E, Toney C, et al. Intravenous hydration for management of medication-resistant orthostatic intolerance in the adolescent and young adult. Pediatr Cardiol. 2016; 37:278–82.

18. Rothner AD. Headaches in children and adolescents: update 2001. Semin Pediatr Neurol. 2001; 8:2–6.

19. Zhang Y, Kong Q, Chen J, Li L, Wang D, Zhou J. International Classification of Headache Disorders 3rd edition beta-based field testing of vestibular migraine in China: demographic, clinical characteristics, audiometric findings and diagnosis statues. Cephalalgia. 2016; 36:240–8.

20. Longoni M, Agostoni EC. Headache in neurological emergency. Neurol Sci. 2020; 41(Suppl 2):409–16.

21. Thigpen MC, Whitney CG, Messonnier NE, Zell ER, Lynfield R, Hadler JL, et al. Bacterial meningitis in the United States, 1998-2007. N Engl J Med. 2011; 364:2016–25.

22. Kelly M, Strelzik J, Langdon R, DiSabella M. Pediatric headache: overview. Curr Opin Pediatr. 2018; 30:748–54.

23. Medina LS, Pinter JD, Zurakowski D, Davis RG, Kuban K, Barnes PD. Children with headache: clinical predictors of surgical space-occupying lesions and the role of neuroimaging. Radiology. 1997; 202:819–24.

24. Manoyana A, Angkurawaranon S, Katib S, Wiwattanadittakul N, Sirikul W, Angkurawaranon C. Diagnostic values of red flags and a clinical prediction score for emergent intracranial lesions in non-traumatic pediatric headaches. Children (Basel). 2022; 9:863.

25. Bear JJ, Gelfand AA, Goadsby PJ, Bass N. Occipital headaches and neuroimaging in children. Neurology. 2017; 89:469–74.

26. Wang SJ, Juang KD, Fuh JL, Lu SR. Psychiatric comorbidity and suicide risk in adolescents with chronic daily headache. Neurology. 2007; 68:1468–73.

27. Kim JY, Lee JH, Eun SH, Eun BL, Nam SO, Song MK. Psychological characteristics of children and adolescents with headaches. J Korean Child Neurol Soc. 2010; 18:58–65.

28. Powers SW, Gilman DK, Hershey AD. Headache and psychological functioning in children and adolescents. Headache. 2006; 46:1404–15.

29. Lee YJ. Comorbidities of primary headache in children. J Korean Med Assoc. 2017; 60:134–9.

30. Yoon JM, Lee HR, Lee KH. Characteristics of sleep disorders in childhood and adolescence. J Korean Child Neurol Soc. 2007; 15:185–91.

31. National Clinical Guideline Centre (UK). Headaches: diagnosis and management of headaches in young people and adults [Internet]. London: Royal College of Physicians (UK);2012. [cited 2022 Jul 26]. https://www.ncbi.nlm.nih.gov/books/NBK299072/.

32. Hämäläinen ML, Hoppu K, Valkeila E, Santavuori P. Ibuprofen or acetaminophen for the acute treatment of migraine in children: a double-blind, randomized, placebo-controlled, crossover study. Neurology. 1997; 48:103–7.

33. McDonald SA, Hershey AD, Pearlman E, Lewis D, Winner PK, Rothner D, et al. Long-term evaluation of sumatriptan and naproxen sodium for the acute treatment of migraine in adolescents. Headache. 2011; 51:1374–87.

34. Brousseau DC, Duffy SJ, Anderson AC, Linakis JG. Treatment of pediatric migraine headaches: a randomized, double-blind trial of prochlorperazine versus ketorolac. Ann Emerg Med. 2004; 43:256–62.

35. Alfonzo M, Chen L. Acute migraine management in children. Pediatr Emerg Care. 2015; 31:722–7.

36. Richer L, Craig W, Rowe B. Randomized controlled trial of treatment expectation and intravenous fluid in pediatric migraine. Headache. 2014; 54:1496–505.

37. Patniyot IR, Gelfand AA. Acute treatment therapies for pediatric migraine: a qualitative systematic review. Headache. 2016; 56:49–70.

38. Im HJ, Cho SJ. Pharmacotherapy of migraine prevention based on the assessment of headache. J Korean Med Assoc. 2020; 63:644–9.

39. Korean Headache Society. Treatment guideline of pharmacological preventive therapy for episodic migraine. Seoul: Medical Publisher Co;2019.

40. American Headache Society. The American Headache Society Position Statement on integrating new migraine treatments into clinical practice. Headache. 2019; 59:1–18.